Business
Press Release Feb 16 2026
Lupin Limited has informed the Exchange regarding a press release dated February 16, 2026, titled "Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex in Canada".
About this update from Lupin Limited
[{"type":"text","content":" Lupin Limited has informed the Exchange regarding a press release dated February 16, 2026, titled \"Lupin Signs License and Supply Agreement with Spektus to Commercialize Novel Antidepressant DeslaFlex in Canada\". View Attachment","length":378,"tagName":"div"}]